LALISA WADE: Open Payments
NPI 1710161385 · SICILY ISLAND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$133 in 7 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $435 · 2025 $133
Food & beverage: $133
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Lilly USA, LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: CAPLYTA, BREZTRI, MOUNJARO, Auvelity, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
